Our data rule out a role of Fas/Fas ligand interaction in tumor cell lysis by the CD8+ CTL line as MAb to FAS was unable to block CTL lysis of melanoma cells in spite of expression of FAS-L and FAS by the CTL and tumor cells, respectively (Table I). The gene discussed is CD8A; the disease is neoplasm.